연구 동향

모달리티별 최신 연구를 자동 수집합니다 — PubMed(심사 완료)와 bioRxiv(프리프린트·미심사). 신약이 아니라 신기술의 최전선. 제목·저널·링크만 제공하며 본문은 원문에서 확인하세요.

  • Science advances2026-07-17

    지질 나노입자 기반 mRNA 백신에서 별개의 항원 제시 경로가 강력한 T 세포 면역을 유도한다

    A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle-based mRNA vaccines

  • Proceedings of the National Academy of Sciences of the United States of America2026-07-16

    IVT-free, chemically synthesized protein-encoding RNA oligonucleotides for rapid production of personalized cancer vaccines

  • bioRxiv (프리프린트)2026-07-16

    프리프린트·미심사What Do Generative Models Learn About Adaptive Immune Receptor Repertoires? A Benchmark Study

    Würtzen, C. 외 6명백신bioRxiv ↗
  • bioRxiv (프리프린트)2026-07-16

    프리프린트·미심사Subunit vaccination enhances protection conferred by prior Mycobacterium tuberculosis exposure

    Cohen, S. 외 9명백신신경·퇴행성bioRxiv ↗
  • bioRxiv (프리프린트)2026-07-15

    프리프린트·미심사High-Density Wild-Type IL-2 Nanoparticles Preferentially Enhance CD8⁺ T-Cell Expansion and Reprogram the Tumor Microenvironment

    Wang, R. 외 8명백신항암bioRxiv ↗
  • bioRxiv (프리프린트)2026-07-15

    프리프린트·미심사Systemic-to-mucosal trafficking of memory B cells contributes to humoral immunity in the upper respiratory tract

    Piano Mortari, E. 외 22명백신bioRxiv ↗
  • bioRxiv (프리프린트)2026-07-14

    프리프린트·미심사Analysis of SIV Spatiotemporal Dissemination Patterns in Rhesus Macaques During Early Rectal Transmission Demonstrates Systemic Infection Does Not Require Viral Local Amplification at the Entry Portal

    Cheng, Y. 외 9명백신감염병bioRxiv ↗
  • bioRxiv (프리프린트)2026-07-13

    프리프린트·미심사Peptide additives reprogram the lipid nanoparticle corona and enhance gene delivery in a serum-free environment for lung epithelium

    Hu, J. 외 4명백신bioRxiv ↗
  • bioRxiv (프리프린트)2026-07-13

    프리프린트·미심사Learned Immune Architectures of Durable Antibody Responses Across Vaccines

    Hao, S. P. 외 3명백신감염병bioRxiv ↗
  • bioRxiv (프리프린트)2026-07-13

    프리프린트·미심사Oral Administration of Hyperimmune Eggs Induces Mucosal IgA Responses, Anti-Idiotypic Antibodies, and HIV-1 Neutralizing Activity: A Proof-of-Concept Preclinical Study

    Justiz-Vaillant, A. 외 3명백신감염병bioRxiv ↗
  • bioRxiv (프리프린트)2026-07-13

    프리프린트·미심사Identification of HLA-A33-restricted CD8+ T cell epitopes from avian influenza A/H5N1

    Muraduzzaman, A. K. M. 외 9명백신감염병bioRxiv ↗
  • bioRxiv (프리프린트)2026-07-13

    프리프린트·미심사replicateFest: An R Package and Shiny App for Analysis of T Cell Receptor Repertoire Data from the Functional Expansion

    Danilova, L. 외 3명백신항암감염병bioRxiv ↗
  • bioRxiv (프리프린트)2026-07-13

    프리프린트·미심사Computational design of structurally diverse antibody repertoires with drug-like properties

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.